Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/415
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCass, A.en_US
dc.contributor.authorDe Zoysa, J.en_US
dc.contributor.authorJardine, M. J.en_US
dc.contributor.authorGray, Nicholasen_US
dc.contributor.authorHertier, S.en_US
dc.contributor.authorPerkovic, V.en_US
dc.contributor.authorHoward, K.en_US
dc.contributor.authorZuo, L.en_US
dc.contributor.authorGallagher, M. P.en_US
dc.contributor.authorChan, C. T.en_US
dc.date.accessioned2018-06-16T20:33:31Z-
dc.date.available2018-06-16T20:33:31Z-
dc.date.issued2015-
dc.identifier.citation20, (4), 2015, p. 257-265en_US
dc.identifier.otherRIS-
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/415-
dc.description.abstractAims Observational reports suggest extended dialysis hours are associated with improved outcomes. These findings are confounded by better prognostic characteristics among people practising extended hours. The aim of this article is to provide an overview of the methods and baseline characteristics for ACTIVE Dialysis Study participants. Methods This multicentre, randomized, open-label, blinded endpoint-assessment trial randomized participants receiving maintenance haemodialysis therapy to either extended (≥24h) or standard (12-18h) weekly haemodialysis for 12 months. A web-based randomization system used minimization to ensure balanced allocation across regions, dialysis setting and dialysis vintage. The primary outcome is the change in quality of life over 12 months of study treatment assessed by EQ-5D. Secondary outcomes include change in left ventricular mass index assessed by magnetic resonance imaging and safety outcomes including dialysis access events. Results A total of 200 participants were recruited between 2009 and 2013 from Australia (29.0%), China (62.0%), Canada (5.5%) and New Zealand (3.5%). Participants had a mean age of 52 (±12) years and 11.5% were dialysing at home, with a mean duration of 13.9h per week over a median of three sessions. At baseline, 32.5% had a history of cardiovascular disease and 36.5% had diabetes. Conclusion The ACTIVE Dialysis Study has met its planned recruitment target. The participant population are drawn from a range of health service settings in a global context. The study will contribute important evidence on the benefits and harms of extending weekly dialysis hours. The trial is registered at clinicaltrials.gov (NCT00649298). Summary at a Glance This paper forms the background for the soon to be released ACTIVE Dialysis Study - an important study comparing quality of life in patients randomly assigned to conventional or extended hours haemodialysis.<br />en
dc.languageenen
dc.relation.ispartofNephrologyen
dc.titleDesign and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': The ACTIVE Dialysis Studyen_US
dc.typeArticleen_US
dc.identifier.doi678-
dc.subject.keywordsNCT00649298adulten
dc.subject.keywordsarticleen
dc.subject.keywordsAustraliaen
dc.subject.keywordsCanadaen
dc.subject.keywordscardiovascular diseaseen
dc.subject.keywordsChinaen
dc.subject.keywordsclinical featureen
dc.subject.keywordscontrolled studyen
dc.subject.keywordsdiabetes mellitusen
dc.subject.keywordsend stage renal diseaseen
dc.subject.keywordsextended dialysisen
dc.subject.keywordsfemaleen
dc.subject.keywordsfollow upen
dc.subject.keywordsheart left ventricle massen
dc.subject.keywordshemodialysisen
dc.subject.keywordshumanen
dc.subject.keywordsmajor clinical studyen
dc.subject.keywordsmaleen
dc.subject.keywordsmiddle ageden
dc.subject.keywordsmulticenter studyen
dc.subject.keywordsNew Zealanden
dc.subject.keywordsnuclear magnetic resonance imagingen
dc.subject.keywordsobservational studyen
dc.subject.keywordspriority journalen
dc.subject.keywordsquality of lifeen
dc.subject.keywordsrandomizationen
dc.subject.keywordsrandomized controlled trialen
dc.subject.keywordssafetyen
dc.subject.keywordsstudy designen
dc.subject.keywordstreatment durationen
dc.subject.keywordstreatment outcomeen
dc.subject.keywordsvascular accessen
dc.relation.urlhttp://linksource.ebsco.com/ls.b6e6cc08-c492-42af-aec4-c6084e18e68c.true/linking.aspx?sid=EMBASE&issn=14401797&id=doi:10.1111%2Fnep.12385&atitle=Design+and+participant+baseline+characteristics+of+%27A+Clinical+Trial+of+IntensiVE+Dialysis%27%3A+The+ACTIVE+Dialysis+Study&stitle=Nephrology&title=Nephrology&volume=20&issue=4&spage=257&epage=265&aulast=Jardine&aufirst=Meg+J.&auinit=M.J.&aufull=Jardine+M.J.&coden=NEPHF&isbn=&pages=257-265&date=2015&auinit1=M&auinitm=J.en
dc.relation.urlhttp://www.embase.com/search/results?subaction=viewrecord&from=export&id=L603285817http://dx.doi.org/10.1111/nep.12385en
dc.identifier.risid678en
dc.description.pages257-265en
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
Appears in Sites:Queensland Health Publications
Sunshine Coast HHS Publications
Show simple item record

Page view(s)

460
checked on May 21, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.